Close Menu

NEW YORK (GenomeWeb) – Singapore's Imagene Labs and New York-based LifeNome announced they are expanding their partnership on so-called "wellness genomics" to include China and Hong Kong.

Imagene Labs will incorporate LifeNome's bioinformatics platform into its consumer genomics testing products to be offered in both markets. Imagene said in a statement that it is building genetic testing facilities in China and plans to offer "personalized genomics guidance on nutrition, fitness, skin care, allergy potentials, and other wellness insights" by early 2017.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

The UK is investing £33.6 million into a controversial human SARS-CoV-2 challenge study, according to Reuters.

The Guardian reports that the UK COVID genomics consortium is monitoring mutations that are arising within circulating SARS-CoV-2 strains for any that may affect future vaccines.

Science reports that Max Planck and Nature have struck a deal for affiliated authors to publish papers that are accessible to the public as well as access Nature-branded journals.

In PNAS this week: genomic analysis of ancient animals from Tibet, oncoproteins tied to WEE1 kinase enzyme inhibitor response, and more.